The goal of this track is two fold. The first overall goal is to communicate late scientific findings and open up ISBI to a broader audience of imaging scientists (in particular from the biology, radiology, and physics communities) and to encourage cross-fertilization. The scope of the abstract track is complementary to the regular track with the aims of (a) stimulating future algorithmic, mathematical, and computational contributions by the traditional ISBI community, and (b) promoting the transfer of advanced algorithms to the practice of bio-imaging. Authors of full-length papers that were not accepted for the regular submission track but received positive reviews are encouraged to submit their work as a one-page abstract.
The second overall goal is to provide a forum for presentation of a selection of manuscripts published by IEEE journals that are sponsored by the the ISBI-sponsoring societies, i.e., the IEEE Signal Processing Society (SPS) and the IEEE Engineering in Medicine and Biology Society (EMBS), as follows. All peer-reviewed journal papers published by EMBS or SPS during 2022 whose topic lies within the domains of biomedical imaging and image analysis are eligible for presentation at ISBI 2023, subject to space availability and approval by the ISBI Program Chairs. Requests for the presentation of such papers should be made by submitting a one-page abstract of the paper through the ISBI 2023 website on or before the submission deadline.
You can consider submitting an abstract to ISBI, if any of the following are true.
If you are an IEEE-journal author whose paper was published in 2022, and would like to gain publicity for your work not presented previously to the ISBI community, then consider submitting an abstract based on your published journal paper.
You will have the unique opportunity to meet physicists and engineering experts in image acquisition and image processing, to form new collaborations, to attend a variety of plenary and keynote talks, tutorials, and special sessions reviewing the fundamentals as well as the state of the art.
Prepare a presentation following the posted guidelines.
ISBI supports the standard requirements on the use of animal and human subjects for scientific and biomedical research. For all ISBI-2023 papers reporting data from studies involving human and/or animal subjects, formal review and approval, or formal review and waiver, by an appropriate institutional review board or ethics committee is required and should be stated in the papers. For those investigators whose institutions do not have formal ethics review committees, the principles outlined in the Helsinki Declaration of 1975, as revised in 2000, should be followed.
Irrespective of whether animal/human data was used, authors should include a statement on ethical compliance in their manuscript.
IEEE-ISBI supports the disclosure of financial support for the project as well as any financial and personal relationships of the author that could create even the appearance of bias in the published work. The authors must disclose any agency or individual that provided financial support for the work as well as any personal or financial or employment relationship between any author and the sources of financial support for the work.
Irrespective of whether a conflict of interest exists, authors should disclose any real or potential conflict of interest, or the absence thereof, in their manuscript.
In case of any questions, please contact the organizing team at IEEEISBI-Support@listserv.ieee.org